Notice – Release of ICH E9(R1): Defining the Appropriate Estimand for a Clinical Trial/ Sensitivity Analyses

Health Canada is pleased to announce the implementation of International Council for Harmonisation of Technical Requirements of Pharmaceuticals for Human Use (ICH) Guidance E9(R1): Defining the Appropriate Estimand for a Clinical Trial/ Sensitivity Analyses.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2023-11-01

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data